Former OBIO CAAP Company Vasomune Announces Multi-Million Dollar Co-Development Agreement
Former OBIO CAAP company Vasomune announced an innovative global Co-Development Agreement with AnGes Inc for the development and commercialization of therapeutics treating diseases associated with blood vessel dysfunction and destabilization.